MCK vs. EW
Compare and contrast key facts about McKesson Corporation (MCK) and Edwards Lifesciences Corporation (EW).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MCK or EW.
Correlation
The correlation between MCK and EW is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
MCK vs. EW - Performance Comparison
Loading data...
Key characteristics
MCK:
1.04
EW:
-0.36
MCK:
1.41
EW:
0.00
MCK:
1.24
EW:
1.00
MCK:
1.17
EW:
-0.17
MCK:
2.88
EW:
-0.40
MCK:
9.73%
EW:
22.98%
MCK:
27.75%
EW:
41.22%
MCK:
-82.83%
EW:
-54.32%
MCK:
-2.16%
EW:
-41.17%
Fundamentals
MCK:
$85.29B
EW:
$45.10B
MCK:
$25.72
EW:
$2.42
MCK:
26.53
EW:
31.77
MCK:
1.08
EW:
4.28
MCK:
0.24
EW:
8.17
MCK:
5.04
EW:
4.44
MCK:
$359.05B
EW:
$5.54B
MCK:
$13.13B
EW:
$4.39B
MCK:
$5.13B
EW:
$1.77B
Returns By Period
In the year-to-date period, MCK achieves a 24.15% return, which is significantly higher than EW's 3.85% return. Over the past 10 years, MCK has underperformed EW with an annualized return of 12.19%, while EW has yielded a comparatively higher 13.39% annualized return.
MCK
24.15%
2.01%
16.09%
28.73%
40.06%
12.19%
EW
3.85%
8.65%
16.20%
-14.73%
1.61%
13.39%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MCK vs. EW — Risk-Adjusted Performance Rank
MCK
EW
MCK vs. EW - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for McKesson Corporation (MCK) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MCK vs. EW - Dividend Comparison
MCK's dividend yield for the trailing twelve months is around 0.39%, while EW has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCK McKesson Corporation | 0.39% | 0.47% | 0.50% | 0.54% | 0.72% | 0.95% | 1.16% | 1.32% | 0.80% | 0.80% | 0.53% | 0.46% |
EW Edwards Lifesciences Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
MCK vs. EW - Drawdown Comparison
The maximum MCK drawdown since its inception was -82.83%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for MCK and EW. For additional features, visit the drawdowns tool.
Loading data...
Volatility
MCK vs. EW - Volatility Comparison
The current volatility for McKesson Corporation (MCK) is 7.23%, while Edwards Lifesciences Corporation (EW) has a volatility of 8.35%. This indicates that MCK experiences smaller price fluctuations and is considered to be less risky than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MCK vs. EW - Financials Comparison
This section allows you to compare key financial metrics between McKesson Corporation and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MCK vs. EW - Profitability Comparison
MCK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, McKesson Corporation reported a gross profit of 3.64B and revenue of 90.82B. Therefore, the gross margin over that period was 4.0%.
EW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported a gross profit of 1.11B and revenue of 1.41B. Therefore, the gross margin over that period was 78.8%.
MCK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, McKesson Corporation reported an operating income of 1.59B and revenue of 90.82B, resulting in an operating margin of 1.8%.
EW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported an operating income of 409.90M and revenue of 1.41B, resulting in an operating margin of 29.0%.
MCK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, McKesson Corporation reported a net income of 1.26B and revenue of 90.82B, resulting in a net margin of 1.4%.
EW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported a net income of 358.00M and revenue of 1.41B, resulting in a net margin of 25.3%.